No profile data available.
Accuray Incorporated (ARAY) is a healthcare company in the targeted healthcare equipment industry, based in Madison, United States, with about 809 full-time employees.
It reported revenue of $401.95 million for fiscal year 2026, down 12.3% from fiscal year 2025, and net income of -$49.19 million. Its largest business segment, Service, brought in 57% of segment revenue in fiscal year 2026; EIMEA was the largest region with 38%. Its market capitalization was $27.44 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
Accuray reported $401.95 million in revenue for fiscal year 2026, down 12.3% from $458.51 million in fiscal year 2025.
Service, with $229.24 million or 57% of segment revenue in fiscal year 2026. Next: Product (43%).
EIMEA: 38% of revenue by region in fiscal year 2026, followed by Americas (22%).
$27.44 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Veru Inc. (VERU), Nephros, Inc. (NEPH), Rockwell Medical, Inc. (RMTI), Abvc BioPharma, Inc. (ABVC).